Research programme: broad spectrum antibiotics - Curza
Alternative Names: Antibiofilm antibiotics programme - Curza; CZ-02 programme - Curza; Ribosomal antibiotics programme - CurzaLatest Information Update: 28 Aug 2023
At a glance
- Originator Curza
- Class Anti-infectives; Antibacterials; Small molecules; Urinary anti-infective agents
- Mechanism of Action Bacterial biofilm inhibitors; Protein biosynthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Infections; Nosocomial pneumonia; Urinary tract infections
- No development reported Gram-negative infections; Gram-positive infections
Most Recent Events
- 28 Aug 2023 No recent reports of development identified for research development in Gram-negative-infections in USA
- 28 Aug 2023 No recent reports of development identified for research development in Gram-positive-infections in USA
- 09 Jan 2023 Preclinical trials in Infections in USA (IM) (Curza pipeline, January 2023)